MarketCapExport financials
Magellan Health, Inc. (MGLN)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
TelegramMagellan Health, Inc. Balance Sheet 2020-2011 | MGLN
Brief overview of Magellan Health, Inc.'s financial position
Balance sheet changes are traced across five available annual reports between 2016 and 2020.
Over the period, assets gained +37.5%, moving from $2.4 billion to $3.4 billion. CAGR near 8.3% shows consistent growth.
Assets outpaced liabilities, +37.5% versus +10.9%. Dependence on external funding declined.
The balance sheet holds more cash than interest-bearing debt; net debt is -$506.1 million, indicating minimal leverage.
By the end of the period, accumulated earnings were $1.9 billion; the change from the start was +44%.
Balance sheet takeaway
Magellan Health, Inc. shows a high-quality balance sheet profile, with adequate internal capital and room for maneuver.
Annual Balance Sheet Magellan Health, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-506 M | 357 M | 481 M | 455 M | 314 M | 142 M | 16.2 M | -176 M | -189 M | -120 M |
Long Term Debt |
632 M | 679 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
752 M | 784 M | 795 M | 788 M | 251 M | 279 M | 375 M | 126 M | 102 M | 126 M |
Total Current Liabilities |
738 M | 910 M | 899 M | 892 M | 1.09 B | 724 M | 586 M | 476 M | 393 M | 370 M |
Total Liabilities |
1.49 B | 1.69 B | 1.69 B | 1.68 B | 1.34 B | 1 B | 961 M | 603 M | 495 M | 496 M |
Deferred Revenue |
1.84 M | - | - | - | - | - | - | - | - | - |
Retained Earnings |
1.86 B | 1.48 B | 1.42 B | 1.4 B | 1.29 B | 1.21 B | 1.18 B | 1.1 B | 975 M | 824 M |
Total Assets |
3.36 B | 3.09 B | 2.98 B | 2.96 B | 2.44 B | 2.07 B | 2.09 B | 1.76 B | 1.51 B | 1.34 B |
Annual performance
Select metrics to display
All numbers in USD currency
Balance Sheet is a fundamental financial report of Magellan Health, Inc., providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Health care
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Molina Healthcare
MOH
|
$ 214.9 | -2.26 % | $ 11.3 B |  USA |
 |
Centene Corporation
CNC
|
$ 70.24 | -0.83 % | $ 34.6 B | USA |
 |
UnitedHealth Group Inc.
UNH
|
$ 417.0 | -0.54 % | $ 379 B | USA |
 |
Humana
HUM
|
$ 425.42 | -0.46 % | $ 51.2 B | USA |
 |
NovoCure Limited
NVCR
|
$ 15.59 | -0.76 % | $ 1.74 B |  Jersey |
 |
Triple-S Management Corporation
GTS
|
- | 0.28 % | $ 847 M | USA |
 |
Cigna Corporation
CI
|
$ 304.37 | -0.82 % | $ 80.2 B | USA |
 |
CVS Health Corporation
CVS
|
$ 93.45 | -1.34 % | $ 118 B | USA |
 |
Anthem
ANTM
|
- | -2.32 % | $ 107 B | USA |